+ All Categories
Home > Documents > Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of...

Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of...

Date post: 22-Dec-2015
Category:
Upload: rudolph-terry
View: 222 times
Download: 3 times
Share this document with a friend
Popular Tags:
27
Alcohol, Tobacco and Other Drug Problems in Occupational Health Settings in India: Need for Primary Care Based Brief Intervention Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government of India
Transcript
Page 1: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Alcohol, Tobacco and Other Drug Problems in Occupational Health Settings in India: Need for Primary Care Based Brief Intervention

Amit Chakrabarti, MDScientist “E” (Deputy Director – Medical)National Institute of Occupational Health

Indian Council of Medical ResearchGovernment of India

Page 2: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

OutlineExtent of alcohol, tobacco and other drug

problems among occupational groups in India and its consequences

Need for primary care and community based screening, brief intervention and referral

Initiation of a primary care and community based trial among coal mine workers

Page 3: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Labor Sector in IndiaSize of labor sector in 2013China: 793 millionIndia: 481 millionUnited States: 158 million

Page 4: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Summary of Studies

Page 5: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Patterns & Consequences of Alcohol Misuse in IndiaNIMHANS, Bangalore; WHO; Government of India;

Collaborating centresObjective: Impact of alcohol misuse on health and socio-

economic wellbeing of users and their families and harms to persons in contact with users

Five regions: Cuttack – Odisha (sparse data on alcohol use, with poorer economic indicators); Dhule – Maharashtra (one of the most backward districts), Gangtok – Sikkim (large proportion of the population using traditional home brew / illicit alcohol), Surat – Gujarat (a state under long-time prohibition), Vishakapatnam – Andhra Pradesh (anecdotal reports suggested a high prevalence of alcohol use with rapidly changing economic parameters)

Page 6: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 7: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 8: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 9: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 10: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 11: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

OutlineExtent of alcohol, tobacco and other drug

problems among occupational groups in India and its consequences

Need for primary care and community based screening, brief intervention and referral

Initiation of a primary care and community based trial among coal mine workers

Page 12: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

NeedSocial cost for an alcohol dependent INR

30,000 / mo (Benegal et al, 2000) Expenditure on alcohol dependence by State

is much higher compared to excise revenue generated (INR 18 billion vs. 8.5 billion) (Benegal et al, 2000)

70% of economic cost of alcohol abuse can be attributed to loss in productivity (WHO, 2003)

Page 13: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Contd.Current addiction treatment facility

inadequate to provide treatment for dependents

Harmful users below the tip of the iceberg have to be provided intervention at the primary care and community level

Primary care and community based, cost-effective early detection, brief intervention and referral is the key

Page 14: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

OutlineExtent of alcohol, tobacco and other drug

problems among occupational groups in India and its consequences

Need for primary care and community based screening, brief intervention and referral

Initiation of a primary care and community based trial among coal mine workers

Page 15: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

PopulationCoal industry in India is one of the largest with a

turnover of INR 80,000 crore (US$ 13,000 million) and worker strength of approximately 3,60,000

However, regular consumption of tobacco and alcohol among workers in mining higher among occupational groups (almost 40%) increasing to almost 70% among workers with occupational injuries (Kunar et al., 2008)

In absolute terms, at least 1,10,000 workers in Indian coal mines are prone to adverse consequences of harmful substance use

Page 16: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

ObjectivesASSIST and biomarker screening to identify

patterns of tobacco, alcohol and cannabis useBrief intervention as secondary prevention

among “hazardous and harmful” usersBrief intervention with add-on

pharmacological intervention among “dependent” users with alcohol as the main problem

Page 17: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Primary ScreeningHave you consumed alcohol, cannabis in any form

(eaten/beverage/smoked) and / or tobacco (smoked/smokeless) in any form during past one year?

Have you consumed alcohol, cannabis in any form (eaten/beverage/smoked) and / or tobacco (smoked/smokeless) in any form during the past 30 days?

Any worker responding “yes” to both questions for any or more than one substance recruited

Any worker responding “no” to any of the questions excluded

Page 18: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Allocation“Low-risk” for all substances provided general health advice &

excluded “Hazardous and harmful” participants randomly allocated:a) “Only screening” (ASSIST and biomarker screening and general

health advice) orb) “Screening and brief intervention (BI)” group (ASSIST and

biomarker screening and general health advice with add-on brief intervention).

“Dependent” users with alcohol as the main problem receive ASSIST and biomarker screening; general health advice; brief intervention along with add-on primary care based, supervised, randomized, double-blind:

c) Acamprosate two tablets of 333 mg (i.e., 666 mg) three times a day (i.e., 1,998 mg/d) for 3 months (12 weeks) or

d) Baclofen tablet of 20 mg three times a day (i.e., 60 mg/d) for 3 months (12 weeks)

Page 19: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.
Page 20: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

ProceduresGENACIS (Gender, Alcohol and Culture: An

International Study) modified questionnaire with Harms to Others (H2O) (Wilsnack, 2009)

WHO Health and Work Performance Questionnaire (HPQ) (Kessler, 2003)

SF-36 questionnaire – Quality of life (Brazier et al., 1992)

Biomarker screening – EDTA whole blood PEth; and urinary cotinine and THC-COOH measured by ELISA

Health screening: Physical – All systems physical; Biochemical; Pulmonary function test (PFT)

Page 21: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Follow Up & Outcome MeasuresGeneral health advice and brief intervention on

recruitment; 3 and 6 monthsPharmacological intervention according to protocol

with follow ups at 3 and 6 monthsASSIST, Harms to Others (H2O), HPQ (Work

Performance domain only), SF-36, biomarker screening, health screening (physical, biochemical and PFT) after 3 and 6 months

Outcome measures will be ASSIST score; biomarker status; health status (physical, biochemical, PFT); absenteeism, injury, sickness, lost productivity, quality of life, harms to others

Page 22: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Preliminary ObservationsOut of n=21 with primary screening 90%

eligibleMean age 47.2±9.2 yearsAlmost 80% work 48 h or more64% do not perceive any work stressUser: Alcohol 90%, tobacco 81%, cannabis

19%ASSISTAlcohol: 10 = 14%; 26 = 44%; 27+ = 42%Tobacco: 3 = 19%; 26 = 76%; 27+ = 5%Cannabis: 3 = 25%; 26 = 75%

Page 23: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Contd.14% participants with ASSIST alcohol score

11 to 15 doing ok42% participants with ASSIST alcohol score

27+ actively seek medicationDrink size for unrecorded / non-commercial /

traditional or illicit alcoholFamily and health are key messages in BI;

also lifestyle modification as in other non-communicable diseases

Page 24: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Concluding CommentsATOD is a problem among occupational groups in

India; probably more than in general populationExisting addiction treatment facilities inadequateEarly brief intervention for high-risk harmful

user population has to be integrated at primary care and community

In the present study 6-month BI protocol per participant costs approximately INR 18,775 (US$ 310) vs. approximate economic cost of only harmful alcohol use INR 90,000 (US$ 1500) over 6 months (Gururaj, 2011)

Page 25: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Acknowledgement1. Vivek Benegal, MD; Professor of Psychiatry, Centre for Addiction

Medicine, NIMHANS, Bangalore2. Malay Ghosal, MD; Professor of Psychiatry, Medical College &

Hospital, Calcutta 3. Jayjit Mukherjee, MBBS, Medical Superintendent, Eastern Coalfields

Funding4. National Institute of Occupational Health, India5. Indian Council of Medical Research, New Delhi

Page 26: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

Thank you!

Page 27: Amit Chakrabarti, MD Scientist “E” (Deputy Director – Medical) National Institute of Occupational Health Indian Council of Medical Research Government.

References1. Benegal V, Velayudhan A, Jain S. The Social Cost of Alcoholism (Karnataka). NIMHANS Journal. 2000;

18(1&2):67-76. 2. Benegal V. Report “Patterns & consequences of alcohol misuse in India - an epidemiological survey”;

NIMHANS, Bangalore & WHO; 2012. 3. Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L.

(1992). Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Bmj, 305(6846), 160-164.

4. Gururaj G, Girish N, Benegal V. Alcohol control series 1: Burden and socio-economic impact of alcohol - The Bangalore Study. New Delhi: World Health Organization, Regional Office for South East Asia; 2006.

5. Gururaj G, Pratima Murthy, Girish N & Benegal V. Alcohol related harm: Implications for public health and policy in India, Publication No. 73, NIMHANS, Bangalore, India; 2011.

6. Kessler, R. C., Barber, C., Beck, A., Berglund, P., Cleary, P.D., McKenas, D., Pronk, N., Simon, G., Stang, P., Üstün, T.U., Wang, P. (2003). The World Health Organization Health and Work Performance Questionnaire (HPQ). Journal of Occupational and Environmental Medicine, 45(2), 156-174.

7. Kunar, B. M., Bhattacherjee, A., & Chau, N. (2008). Relationships of job hazards, lack of knowledge, alcohol use, health status and risk taking behavior to work injury of coal miners: a case-control study in India. [Research Support, Non-U.S. Gov't]. J Occup Health, 50(3), 236-244.

8. WHO. (2003). Investing in Mental Health. Department of Mental Health and Substance Dependence, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.

9. Wilsnack, R. W., Wilsnack, S.C., Kristjanson, A.F., Vogeltanz-Holm, N.D., Gmel, G. (2009). Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction, 104(9), 1487-1500.


Recommended